EDGAR Filing Documents for 0001658551-17-000001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001658551-17-000001

Filing Date

2017-08-04

Accepted

2017-08-04 12:43:33

Documents

Effectiveness Date

2017-08-04

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	10517
	Complete submission text file	0001658551-17-000001.txt		11561

Mailing Address 210 BROADWAY #201 CAMBRIDGE MA 02139

Business Address 210 BROADWAY #201 CAMBRIDGE MA 02139 617-571-8872

Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)